Community Music Event Benefits Cancer Research
A portion of ticket and auction proceeds from the 2012 Rusty Ball will benefit the GIVEHOPE Pancreatic Cancer Research and Awareness Fund. Together with BSI Engineering, GIVEHOPE provides funding support for an ongoing pancreatic cancer research pilot grant program at the UC Cancer Institute. The group awarded its first pilot grant in 2012 to Vladimir Bogdanov, PhD, a pancreatic cancer researcher affiliated with the UC Cancer Institute and UC College of Medicine.
The fifth annual Rusty Ball, hosted by the Rusty Griswolds, will be held on Nov. 10, 2012. Last year this event helped 119 local charities. GIVEHOPE was a beneficiary in 2011 and has been selected again for 2012.
The nonprofit will receive a portion of ticket proceeds and certain auction items. GIVEHOPE will be auctioning two autographed guitarsone signed by the Doobie Brothers, the other by the band Chicagotwo trips to Chicago and a two-flight glider package from the Caesar Creek Soaring Club. Learn more about the event and purchase tickets at http://tickets.therustyball.com/eventperformances.asp?evt=9. Make sure to designate "GIVEHOPE as your beneficiary.
Related Stories
UC experts say proper produce washing is key defense against Cyclospora
July 17, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
UC students organize free health clinic in community
July 15, 2026
The University of Cincinnati student chapter of Remote Area Medical held its annual free health clinic July 11-12 at St. Xavier High School. Medical, dental and vision care was offered to adults and children, with no income requirements or insurance needed.
University of Cincinnati advances FLASH radiation therapy with new clinical trial
July 15, 2026
UC Cancer Center researchers led the FAST-02 trial, showing ultra-high-dose-rate FLASH proton therapy near the heart and lungs safely reduced pain from thoracic bone metastases.